APA

Risner M. E., Saunders A. M., Altman J. F. B., Ormandy G. C., Craft S., Foley I. M., Zvartau-Hind M. E., Hosford D. A. & Roses A. D. (20060918). Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. : The pharmacogenomics journal.

Chicago

Risner M E, Saunders A M, Altman J F B, Ormandy G C, Craft S, Foley I M, Zvartau-Hind M E, Hosford D A and Roses A D. 20060918. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. : The pharmacogenomics journal.

Harvard

Risner M. E., Saunders A. M., Altman J. F. B., Ormandy G. C., Craft S., Foley I. M., Zvartau-Hind M. E., Hosford D. A. and Roses A. D. (20060918). Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. : The pharmacogenomics journal.

MLA

Risner M E, Saunders A M, Altman J F B, Ormandy G C, Craft S, Foley I M, Zvartau-Hind M E, Hosford D A and Roses A D. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. : The pharmacogenomics journal. 20060918.